Introduction
IL-20 is identified as a member of the IL-10 family, 1 which includes IL-10, -19, -20, -22, -24 (MDA-7), and -26 (AK155). [2] [3] [4] Overexpression of IL-20 in transgenic mice causes neonatal death and aberrant epidermal differentiation.
1 IL-20 is preferentially expressed in monocytes, 5 and selectively enhances multipotential hematopoietic progenitors in vitro and in vivo.
6 IL-20 induces STAT3 activation on keratinocytes through binding to two types of IL-20 receptor (R) complexes, either IL-20R1 and IL-20R2 or IL-20R2 and IL-22R1. 7 Angiogenesis is complex in both physiological and pathophysiological processes, and is regulated through the production of several pro-angiogenic and antiangiogenic factors. Normally, inhibitory factors, such as endostatin, predominate, but various signals can tip the finely tuned balance in favor of angiogenesis -the 'angiogenic switch'. Angiogenic factors -in particular, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) -activate endothelial cells, which leads to the secretion and activation of matrix metalloproteinases (MMPs) 8 and plasminogen activators. This results in the degradation of the basement membrane, which allows the endothelial cells to invade the surrounding matrix.
Little is known about the in vitro biological function of IL-20. Endothelial cells expressed IL-20 receptors, IL-20R1 and IL-20R2. 9 Our aims, therefore, were to explore whether IL-20 was involved in the process of angiogenesis. We treated human umbilical vein endothelial cells (HUVECs) with human (h)IL-20 and monitored the proliferation, migration, and differentiation of the cells. 
Results

Isolation of hIL-20 splice variant
We used a pair of hIL-20-specific primers to amplify hIL-20 transcript on a panel of human cDNA libraries including normal tissues of the kidney, lung, spleen, lymph node, thymus, bone marrow, brain, fetal liver, placenta, heart, testis, liver, and small intestine. PCR analysis showed that hIL-20 has two different transcripts. One is identical to what was reported (accession number AF224266) and named 'wild type' (hIL-20W). The other, a shorter transcript variant, was named 'short form'. The wild type is expressed in the kidney, lung, and placenta tissues. The alternatively spliced variant (short form, hIL-20S) was found in the lung tissue only (Figure 1a) . The hIL-20 gene was predicted to contain five exons and four introns. Exon 4 was deleted in the hIL-20 short form (Figure 1b ).
IL-20-induced proliferation of HUVECs and HMECs
Endothelial cells expressed IL-20 receptors, IL-20R1 and IL-20R2. Therefore, we expressed and purified recombinant proteins of hIL-20W and hIL-20S from Escherichia coli and explored whether hIL-20 targeted on endothelial cells. We treated HUVECs with either hIL-20W or hIL-20S and analyzed their effect on endothelial cell proliferation. We used bFGF (10 ng/ml) as a positive control. Human IL-20W induced proliferation of HUVECs at concentrations between 100 and 200 ng/ml, while hIL-20S induced proliferation of HUVECs at concentrations between 25 and 200 ng/ml (Figures 2a  and b) . To confirm the specificity of IL-20-induced proliferation of HUVECs, we used the anti-hIL-20 monoclonal antibody, 7E, to neutralize hIL-20. While 7E per se did not affect the proliferation of HUVECs, it blocked the proliferation of HUVECs induced by hIL-20W and hIL-20S (Figures 2c and d) . In addition to HUVECs, we also treated human microvascular endothelial cells (HMECs) with IL-20 and analyzed the proliferation response. IL-20W and IL-20S also induced proliferation of HMECs, and the activity of IL-20 was neutralized by 7E (Figures 2e and f) . The concentration required for hIL-20S was lower than that for hIL-20W, suggesting that hIL-20S may be more potent. domain of the receptors and expressed the soluble  receptors to analyze whether the soluble receptors block  IL-20 activity. hIL-20W or hIL-20S at their optimal  concentrations was incubated with sIL-20R1 or sIL-20R2 at 41C for 30 min before being used to treat the  HUVECs and HMECs. Soluble IL-20R1 or IL-20R2 alone had no effect on HUVEC proliferation. The IL-20-induced proliferation was attenuated by hIL-20W or hIL-20S pre-incubated with sIL-20R1 (Figure 3a and c) and was completely abolished by hIL-20W or hIL-20S pre-incubated with sIL-20R2 (Figure 3b and d) .
Interaction of IL-20 and IL-10 IL-10 is a potent anti-inflammatory cytokine that inhibits the release of TNF-a, IL-1, IL-6, and IL-8 from monocytes, macrophages, and neutrophils.
10,11 IL-10 also blocks VEGF-and FGF-2-induced proliferation of microvascular endothelial cells in vitro. 12 These observations suggest a potent role for IL-10 in the prevention of angiogenesis. With the paradigm of the inflammatory nature of angiogenesis, we tested the hypothesis that IL-10 may antagonize the IL-20-induced proliferation. Various concentrations of IL-10 were added to the optimal concentration of hIL-20W (200 ng/ml) or hIL-20S (50 ng/ml) and co-incubated with HUVECs for 60 h. IL-10 at concentrations between 12.5 and 200 ng/ml did not affect the HUVEC proliferation per se ( Figure 4a) ; it antagonized the hIL-20W-and hIL-20S-induced proliferation (Figures 4b and c) .
Effects of IL-20 on endothelial cell migration Angiogenesis is a biological process whereby endothelial cells divide and migrate to form new blood vessels. To investigate whether IL-20 plays a role in angiogenesis, we treated HUVECs with either hIL-20W or hIL-20S for 4 h and analyzed their effects on the migration of endothelial cell by using the Boyden chamber. hIL-20W (200 ng/ml) or hIL-20S (50 ng/ml) was added to the lower chamber. M199 medium with 0.1% FBS was used as a negative control and bFGF was used as a positive control. The number of HUVECs on the lower surface of the filter was determined microscopically. As shown in Signal transduction pathway of IL-20 in HUVECs IL-20 was shown to act on keratinocytes through the STAT3 signal transduction pathway. 1 However, we did not detect significant phosphorylation of STAT3 in HUVECs (data not shown). The ERK pathway, which is activated by many growth factors, may mediate endothelial cell proliferation and migration. It has also been reported that p38 MAPK activation by VEGF mediates actin reorganization and cell migration in HUVECs and thus may be an important regulator of angiogenesis. JNK, one of the MAPK members, is also involved in the regulation of cell migration and cytoskeletal integrity. To assess whether ERK1/2, p38, and JNK activities were involved in the IL-20-induced HUVEC proliferation and migration, we studied the effects of IL-20 on ERK1/2, p38, and JNK phosphorylation using Western blotting. Both IL-20W and IL-20S induced ERK1/2, p38, and JNK phosphorylation in HUVECs, whereas total ERK, p38, and JNK proteins remained constant ( Figure 10 ). Induction of phosphorylation by IL-20 was time dependent, with maximal phosphorylation occurring at 2 min (ERK and JNK) and 5 min (p38) (Figure 10) .
Discussion
The present study demonstrated that hIL-20 at concentrations between 25 and 200 ng/ml induced proliferation of HUVECs. The concentration required to induce proliferation of HUVECs or HMECs to 175% was 200 ng/ml for hIL-20W, and 50 ng/ml for hIL-20S. Thus, hIL-20S seems to be a more potent inducer of proliferation than hIL-20W. hIL-20W protein produced from mammalian cells also showed lower activity than hIL-20S at the same dose (data not shown). Our E. coliderived hIL-20W protein also showed the same potency as commercial hIL-20W protein (R&D Systems Inc.) derived from E. coli. Thus, the lower potency of hIL-20W is not due to the expression system or refolding of the recombinant proteins. Exon 4 was spliced out in hIL-20S. The detailed crystallographic structure of IL-20 remains unidentified to date, but the structures of the genes that encode members of the IL-10 family are expected to be highly conserved. Exon 4 encodes the DE Recently, IL-20 was reported to be an anti-angiogenesis cytokine that inhibited COX-2 expression. 16 It was showed that IL-20 downregulates COX-2 and PGE 2 in human bronchial epithelial and endothelial cells. IL-20-dependent inhibition of COX-2/PGE 2 occurs through the IL-22R1/IL-20R2 dimers and exerts anti-angiogenic effects, inhibiting experimental angiogenesis. Our results showed that IL-20 promote angiogenesis in vitro and in vivo. The different results may be attributed to different 
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Matrix metalloproteinases (MMP-9 and MMP-2) have been extensively studied for its contribution to angiogenesis. In vitro studies have shown that MMP-2 is important for the differentiation of endothelial cells into tube-like structures. 19 The role of MMP-9 in in vivo angiogenesis has also been supported by data obtained from mice with targeted disruption of these MMP genes. Mice lacking MMP-9 are viable, but show abnormal development of growth plates in long bones associated with delayed and aberrant vascularization. 20 Our data demonstrated that hIL-20W induced MMP-2 transcript in HUVECs, and that hIL-20S induced both MMP-2 and MMP-9, indicating that hIL-20 may play a crucial role in angiogenic process. We did not detect any MMP-9 transcript from cells treated with human IL-20W, even after two runs of PCR amplification. However, we detected MMP-9 transcript from HMECs treated with either human IL-20W or IL-20S. The difference in molecular mechanisms of these two forms of IL-20 on MMP-9 induction is worth exploring. The tertiary structures of the proteins may shed light on this aspect.
Previous study showed that IL-20 signaled through STAT3 phosphorylation in kerotinocytes. 1 Our results on HUVECs demonstrated that IL-20 did not induce phosphorylation of STAT3; instead, it induced phosphorylation of p38, ERK, and JNK. These three signal transduction pathways are involved in various cellular responses to extracellular signals and are associated with cell proliferation, migration, and differentiation. This novel discovery of signaling provides new insight on the molecular mechanism of IL-20.
In summary, we demonstrated that IL-20 is an angiogenesis factor because it induced proliferation, migration, and vascular tube formation on endothelial cells. It also induced the expression of other angiogenesis factors and MMPs. In vivo, IL-20 enhanced tumor vascularization and increased microvessel density. Thus, IL-20 promotes angiogenesis by itself or through induction of other angiogenesis factors.
Materials and methods
Isolation of hIL-20 spliced variants
We used a pair of primers on exon 1 (sense primer: 5'-CTCCAGATTTCAGGCCTAAGATG-3') and exon 5 (antisense primer: 5'-ATTGAAGACTGGAGCTCTT GACC-3') in PCR amplification to detect the short form transcript on a panel of human cDNA libraries (Clontech, Inc., Palo Alto, CA, USA).
Expression and purification of recombinant hIL-20
Both wild-type (W) and short form (S) hIL-20 were expressed in E. coli. A cDNA-clone coded for the hIL-20 sequences from leucine to leucine (aa 25-176) was inserted into pET43a (Novagen, Madison, WI, USA). A taq of six histidine residues was placed at the C-terminus of the recombinant proteins. The protein was found mostly in the cytosol and was purified to more than 95% using affinity chromatography.
Expression and purification of the extracellular domains of hIL-20R1 and hIL-20R2 recombinant protein RNA was isolated from HaCaT cells and reverse transcribed into cDNA. The extracellular domain of IL-20R1 (shIL-20R1) was amplified with PCR using the sense primer and the antisense primer. The amplified PCR fragment coding from Val to Lys (aa 30-250) was ) were incubated with serum-free M199 medium for 6 h followed by treatment with serum-free M199 medium containing wild-type hIL-20 (150 ng/ml) or short form hIL-20 (50 ng/ml) for 2, 5, 10, 20, and 40 min. Cell lysates were isolated and the levels of phospho-ERK1/2 (Tyr 204), phospho-p38 (Thr-180/Tyr -182), and phospho-JNK were detected using Western blotting with specific antibodies. Total ERK, p38, and JNK were also detected with specific antibodies.
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M-Y Hsieh et al inserted into the E. coli expression vector of pMAL-c2X (NEB, Beverly, MA, USA). The extracellular domain of IL-20R2 (shIL-20R2) was constructed as previously described. 21 A taq of six histidine residues was placed at the C-terminus of the recombinant proteins. Both proteins were purified using metal affinity chromatography.
IL-20 antibody
Human IL-20 monoclonal antibody, 7E, was generated and its specificity was determined as described previously. 21, 22 Cell proliferation assay HUVECs and HMECs were purchased from Cascade Biologicst (Cascade Biologics, Inc., Portland, OR, USA) and plated in 24-well plates at a density of 3 Â 10 4 cells per well. Cells were incubated with various concentrations of hIL-20W or hIL-20S for 48 h in HUVECs and for 72 h in HMECs. Cells were then incubated with a 1-mg/ml solution of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) (Sigma) for 4 h. In total, 200 ml of DMSO (Sigma) was added to the culture. Absorbance of 550 nm was determined. Basic fibroblast growth factor (bFGF) (Peprotech Ec Ltd, London, UK) was used as the positive control in the cell proliferation assay. For neutralization of IL-20 activity, anti-hIL-20 mAb, 7E, or sIL-20R1 or sIL-20R2 proteins were incubated with an optimal concentration of hIL-20S (50 ng/ml) or hIL-20W (200 ng/ml) for 30 min at 41C before treatment.
Cell migration assay
Migration was measured with modified Boyden chamber housing a polycarbonate filter with 8 mm pores (Nucleopore, Cabin John, MD, USA) as described previously. 23 1.5 Â 10 4 cells were placed in the upper compartment of the Boyden chamber. Lower chambers were filled with each chemoattractant, hIL-20W (200 ng/ml), hIL-20S (50 ng/ml), or bFGF (10 ng/ml) in M199 medium with 0.1% FBS. M199 medium with 0.1% FBS was used as a negative control and bFGF was used as a positive control. The chambers were incubated for 4 h at 371C to allow cell migration. The number of HUVECs on the lower surface of the filter was determined microscropically by counting six randomly picked fields (original magnification Â 100). Experiment was performed twice using quadruplicate wells and migration was expressed as the average number7s.d. of total cells counted per field.
Analysis of angiogenesis in vitro and in vivo with Matrigel
In total, 200 ml of Matrigel (BD Biosciences) containing hIL-20W or hIL-20S was added to a 96-well plate and allowed to polymerize for 30 min at 371C. Cell suspensions of HUVECs were plated on Matrigel-coated wells and incubated for 12 h to allow tube formation. The number of tubes was calculated by taking the average tube numbers of triplicate wells. For in vivo tumor angiogenesis assay, mouse hepatoma cells, ML-1 (1 Â 10 6 cells), were dorsally co-injected with Matrigel containing IL-20W (100 ng/ml), IL-20S (100 ng/ml), VEGF (10 ng/ml), or saline. Tumors were excised after 8 days and frozen sectioned for anti-CD31 (PharMingen, San Diego, CA, USA) staining. Slides were incubated with the AEC substrate kit (Vector Laboratories, Burlingame, CA, USA) and counterstained with Mayer's hematoxylin (ThermoShandon, Pittsburgh, PA, USA). Mean microvessel density was counted in six randomly chosen fields (0.16 mm 2 ) at Â 40 magnification as described previously. 18 Detection of induced transcripts for angiogenesis factors using RT-PCR To investigate the induction of bFGF, VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and IL-8 on hIL-20-stimulated HUVECs, cells were exposed to hIL-20W (200 ng/ml) or hIL-20S (50 ng/ml) for 4 h in serum-free M199 medium. Total RNA was extracted and underwent RT-PCR. Amplification of b-actin was used as an internal control. The sequences of the human-specific PCR primers are given in Table 1 . The relative quantity of PCR products was analyzed using the BIO-PROFIL program (Vilbert Lourmat, France).
Analysis of signal transduction
HUVECs (1 Â 10 6 ) were pre-incubated with serum-free M199 medium for 6 h and treated with serum-free M199 medium containing wild-type hIL-20 (150 ng/ml) or short form hIL-20 (50 ng/ml) for 2, 5, 10, 20, and 40 min. Cell lysates were separated using SDS-PAGE. The levels of phospho-ERK1/2 (Tyr 204), phospho-p38 (Thr-180/Tyr-182), and phospho-JNK were detected using Western blotting with specific antibodies (Cell Signaling Technology). 
